Roll-out of HPV vaccine campaigns in Indian schools

2 May 2016

Even as Delhi has become the first state in India to launch the human papilloma virus (HPV) vaccine in schools as part of a public health program, the state of Chennai, which ranks second among metros having a high incidence of cervical cancer, is set to become the second state to launch the HPV vaccine in schools, reports The Pharma Letter’s India correspondent.

Union Health Minister JP Nadda informed the Lok Sabha recently that an estimated 62,416 women died of cervical cancer in 2015-16, accounting for 24% of all women’s cancer cases in India, and 25% of death worldwide.

With close to 17 out of every 100,000 women in Chennai suffering from the disease, a recent study had shown that Bangalore had the highest number of people with 19 out of every 100,000 women, while Delhi came third with 15 cases. Aizwal district, capital of Mizoram, topped the list in the country with 24 cases of every 100,000 women.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK